Xin Cao

机构：Nanjing University of Chinese Medicine, Nanjing Medical University · ORCID：0000-0002-8211-6634

发表论文 67 篇 · 总被引 997 次 · h-index 18

代表论文

• Glucagon‐like peptide‐1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials (2019 · Diabetes/Metabolism Research and Reviews · 被引 105)
• Deletion of OSBPL2 in auditory cells increases cholesterol biosynthesis and drives reactive oxygen species production by inhibiting AMPK activity (2019 · Cell Death and Disease · 被引 45)
• OSBPL2-disrupted pigs recapitulate dual features of human hearing loss and hypercholesterolaemia (2019 · Journal of genetics and genomics/Journal of Genetics and Genomics · 被引 36)
• OSBPL2 deficiency upregulate SQLE expression increasing intracellular cholesterol and cholesteryl ester by AMPK/SP1 and SREBF2 signalling pathway (2019 · Experimental Cell Research · 被引 34)
• OSBPL2 Is Required for the Binding of COPB1 to ATGL and the Regulation of Lipid Droplet Lipolysis (2020 · iScience · 被引 32)
• Mutations in OSBPL2 cause hearing loss associated with primary cilia defects via sonic hedgehog signaling (2022 · JCI Insight · 被引 19)